Lexicon Genetics to Scale Up Functional Genomics Efforts | GenomeWeb

NEW YORK, April 19 - Lexicon Genetics unveiled a new plan Thursday to determine the in vivo function of 1,000 genes per year for the next five years.

The company plans to find the functions of 5,000 genes, approximately the number of drug targets many scientists believe are encoded in the human genome by 2006, Arthur Sands, Lexicon's CEO, said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."